Abiraterone in Prostate Cancer, Survival Gets Even Better - Medscape

[INCIID News Feed]

Moneycontrol.com
<img alt="" height="1" width="1" />
Abiraterone in Prostate Cancer, Survival Gets Even Better
Medscape
June 6, 2011 (Chicago, Illinois) — Abiraterone acetate (Zytiga, Cougar Biotechnology), which was approved recently in the United States, significantly improves survival in men with metastatic castration-resistant prostate cancer. ...
Exelixis drug slows prostate cancer spread in trialReuters
Study Shows Benefit of J&J Prostate Cancer DrugWall Street Journal
Exelixis reports deaths in cancer drug studyForbes
AFP -U.S. News & World Report -RTT News
all 201 news articles &raquo;


More...